To design a mobile app based on the needs of the onco-hematological patient receiving oral antineoplastic agents.
Methods
A multidisciplinary working group (pharmacy–oncology–hematology) was created to design the app. The study was developed in three phases: first, we analyzed the features of patients receiving oral antineoplastic agents. We then analyzed available apps for cancer patients. Finally, we designed the app's functionalities.
Results
We included 51 patients with middle-advanced age (68.7 years (SD=10.7)). They were polymedicated (mean: 5.3 (SD = 2.7), with numerous drug–drug interactions and adverse effects (all patients presented adverse effects). We then analyzed 166 apps. Most apps had more than one use, the most frequent being information (39.8%) and diagnosis (38.6%). Ten apps (6%) were for registering and monitoring treatment and adverse effects. Almost half of the apps (48.8%) were developed by healthcare organizations. Finally, we designed an app (e-OncoSalud®) with the following functionalities: (a) agenda; (b) treatment and drug interactions checker; (c) continuous recording of self-controls (weight, blood pressure, general condition) and adverse effects. The management of the adverse effects are based on an algorithm which provides different recommendations according to the adverse effects severity; (d) patient–pharmacist messaging in real-time; (e) education.
Conclusions
After analysis of the main problems affecting these patients and the needs not covered by the existing apps, we designed e-OncoSalud®. It integrates relevant information about their treatment, focused on drug interactions identification and the prevention, and management of adverse effects.
SawesiSRashrashMPhalakornkuleK, et al.The impact of information technology on patient engagement and health behavior change: a systematic review of the literature. JMIR Med Inform2016; 4: e1.
2.
Aitken M and Lyle J. Patient adoption of mHealth: use, evidence and remaining barriers to mainstream acceptance. Parsippany, New York: IMS Institute for Healthcare Informatics.
3.
San Mauro MartínI. Aplicaciones Móviles En Nutrición, Dietética Y Hábitos Saludables. Nutr Hosp2014; 1: 15–24.
4.
WeaverAYoungAMRowntreeJ, et al.Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol2007; 18: 1887–1892.
5.
BaschEDealAMKrisMG, et al.Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol2016; 34: 557–565.
6.
BenderJLYueRYKToMJ, et al.A lot of action, but not in the right direction: systematic review and content analysis of smartphone applications for the prevention, detection, and management of cancer. J Med Internet Res2013; 15: e287.
7.
Highland J and Clemens H. Mandated benefit review of SB 1070: an act relative to oral cancer therapy. Portland, USA: Compass Health Analytics, 2012.
8.
Collado-BorrellREscudero-VilaplanaVRomero-JiménezR, et al.Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account. J Cancer Res Clin Oncol2016; 142: 2319–2330.
9.
WeingartSNBrownEBachPB, et al.NCCN task force report: oral chemotherapy. J Natl Compr Canc Netw2008; 6: S1–S14.
10.
Collado-BorrellREscudero-VilaplanaVRibed-SánchezA, et al.Smartphone applications for cancer patients; what we know about them?Farm Hosp2016; 40: 25–35.
11.
BrouardBBardoPBonnetC, et al.Mobile applications in oncology: is it possible for patients and healthcare professionals to easily identify relevant tools?Ann Med2016; 48: 509–515.
12.
Lexicomp. Drugs interactions. USA: Wolters Kluwer Clinical Drug Information, Inc.
13.
U.S. Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE). Version 4.03. USA: U.S. Department of Health and Human Services, 2010.
14.
Ortega SuárezFJSánchez PlumedJPérez ValentínMA, et al.Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus. Nefrol Publ2011; 31: 690–696.
MinYHLeeJWShinY-W, et al.Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study. J Med Internet Res2014; 16: e135.
17.
PandeyAHasanSDubeyD, et al.Smartphone apps as a source of cancer information: changing trends in health information-seeking behavior. J Cancer Educ2013; 28: 138–142.
18.
WolfJAMoreauJFAkilovO, et al.Diagnostic inaccuracy of smartphone applications for melanoma detection. JAMA Dermatology2013; 149: 422.
19.
van LeeuwenRWBrundelDHNeefC, et al.Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer2013; 108: 1071–1078.
20.
Torres VJ. Continuidad Asistencial del Paciente con Antineoplásicos Orales. Monografías de la Fundación José Casares Gil 26, 2015.
21.
KimBYSharafoddiniATranN, et al.Consumer mobile apps for potential drug-drug interaction check: systematic review and content analysis using the mobile app rating scale (MARS). JMIR Mhealth Uhealth2018; 6: e74.
22.
CoquanEHenriPde RaucourtS, et al.Management of adverse effects of targeted therapy toxicities in oncology. Rev Prat2012; 62: 17–25.
23.
RavaudA. Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies. Oncologist2011; 16: 32–44.
24.
WeaverALoveSBLarsenM, et al.A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring – supporting patients in their homes. Support Care Cancer2014; 22: 2677–2685.
25.
KearneyNMcCannLNorrieJ, et al.Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer2009; 17: 437–444.
26.
FuMRAxelrodDGuthAA, et al.mHealth self-care interventions: managing symptoms following breast cancer treatment. Mhealth2016; 2: 28.
27.
BC Cancer Agency. Symptom & side effect management resource guide. Canada: BC Cancer Agency.
28.
PutsMTECosta-LimaBMonetteJ, et al.Medication problems in older, newly diagnosed cancer patients in Canada: how common are they? A prospective pilot study. Drugs Aging2009; 26: 519–536.
29.
HarrisJCheeversKArmesJ. The emerging role of digital health in monitoring and supporting people living with cancer and the consequences of its treatments. Curr Opin Support Palliat Care2018; 12: 268–275.
30.
Denis F, Lethrosne C, Pourel N, et al. Overall survival in patients with lung cancer using a web-application-guided follow-up compared to standard modalities: Results of phase III randomized trial. J Clin Oncol 2016; 34 suppl 15:9006.
31.
FishbeinJNNisotelLEMacDonaldJJ, et al.Mobile application to promote adherence to oral chemotherapy and symptom management: a protocol for design and development. JMIR Res Protoc2017; 6: e62.
32.
DayerLHeldenbrandSAndersonP, et al.Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc2013; 53: 172–181.
33.
ParmantoBPramanaGYuDX, et al.iMHere: a novel mHealth system for supporting self-care in management of complex and chronic conditions. JMIR Mhealth Uhealth2013; 1: e10.
34.
MargolisKLAscheSEDehmerSP, et al.Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertensionfollow-up of a cluster randomized clinical trial. JAMA Netw Open2018; 1: e181617.
35.
GraetzIMcKillopCNStepanskiE, et al.Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial. J Cancer Surviv2018; 12: 431–440.
36.
MarinDBazeosAMahonFX, et al.Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol2010; 28: 2381–2388.
37.
World Health Organization. Programme on mental health. WHOQOL. User manual. Geneva: World Health Organization, 1998.
38.
ElsberndAHjermingMVislerC, et al.Cocreated smartphone app to improve the quality of life of adolescents and young adults with cancer (Kræftværket): protocol for a quantitative and qualitative evaluation. JMIR Res Protoc2018; 7: e10098.
39.
RinconEMonteiro-GuerraFRivera-RomeroO, et al.Mobile phone apps for quality of life and well-being assessment in breast and prostate cancer patients: systematic review. JMIR Mhealth Uhealth2017; 5: e187.
